C J Tack Selected Research

C J Tack Research Topics

Disease

19	Type 2 Diabetes Mellitus (MODY) 01/2021 - 07/2001
12	Insulin Resistance 11/2015 - 02/2000
6	Weight Gain 01/2020 - 11/2010
6	Body Weight (Weight, Body) 03/2016 - 09/2010
4	Obesity 10/2023 - 02/2000
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2018 - 10/2006
4	Inflammation (Inflammations) 02/2014 - 09/2005
4	Diabetes Mellitus 10/2006 - 03/2002
3	Weight Loss (Weight Reduction) 10/2023 - 09/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 09/2005
2	Necrosis 02/2018 - 07/2005
2	Infections 03/2014 - 09/2008
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 02/2018
1	Tuberculosis (Tuberculoses) 02/2018
1	Overweight 11/2015
1	Glucose Intolerance 12/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2014
1	Simpson-Golabi-Behmel syndrome 12/2012
1	Heart Failure 10/2011
1	Rheumatoid Arthritis 07/2009
1	Hyperphagia (Overeating) 09/2008
1	Hyperinsulinism (Hyperinsulinemia) 09/2008
1	Cough 10/2006
1	Type 3 Maturity-Onset Diabetes of the Young 09/2001
1	Type 1 Maturity-Onset Diabetes of the Young 09/2001
1	Type 4 Maturity-Onset Diabetes of the Young 09/2001
1	Mason-Type Diabetes 09/2001
1	Hyperglycemia 05/2001
1	Lactic Acidosis 01/2001

Drug/Important Bio-Agent (IBA)

14	Insulin (Novolin)FDA Link 01/2020 - 02/2000
4	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 02/2000
3	Liraglutide FDA Link 10/2023 - 03/2016
3	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 01/2001
3	Interleukin-6 (Interleukin 6)IBA 02/2018 - 07/2005
3	CytokinesIBA 02/2018 - 12/2012
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2020 - 09/2017
2	glimepiride (Amarel)FDA LinkGeneric 01/2020 - 02/2002
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 02/2018 - 12/2014
2	Acarbose FDA LinkGeneric 03/2014 - 03/2002
2	Rosiglitazone (Avandia)FDA Link 04/2011 - 09/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2009 - 07/2005
2	oxidized low density lipoproteinIBA 01/2006 - 09/2005
2	LipidsIBA 01/2006 - 09/2005
2	Triglycerides (Triacylglycerol)IBA 09/2005 - 07/2001
2	C-Reactive ProteinIBA 09/2005 - 07/2005
2	Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA 05/2005 - 09/2001
2	Transcription Factors (Transcription Factor)IBA 05/2005 - 09/2001
2	Adenosine Triphosphate (ATP)IBA 03/2002 - 02/2002
2	Glyburide (Glibenclamide)FDA LinkGeneric 03/2002 - 02/2002
1	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2023
1	semaglutideIBA 10/2023
1	Interleukin-17 (Interleukin 17)IBA 02/2018
1	Pattern Recognition ReceptorsIBA 02/2018
1	InterferonsIBA 02/2018
1	Insulin Aspart (NovoLog)FDA Link 11/2015
1	Short-Acting InsulinIBA 11/2015
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 12/2014
1	Adrenergic Receptors (Adrenergic Receptor)IBA 08/2014
1	Dipeptidyl-Peptidase IV InhibitorsIBA 03/2014
1	VildagliptinIBA 03/2014
1	AdipokinesIBA 02/2014
1	A 17 (A-17)IBA 02/2014
1	Messenger RNA (mRNA)IBA 12/2013
1	Proteins (Proteins, Gene)FDA Link 12/2013
1	Chemotactic FactorsIBA 12/2012
1	Small Interfering RNA (siRNA)IBA 12/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2011
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 10/2011
1	DiureticsIBA 04/2011
1	AlbuminsIBA 09/2010
1	2,4-thiazolidinedione (thiazolidinedione)IBA 09/2010
1	Interferon-gamma (Interferon, gamma)IBA 09/2008
1	Interleukin-18 (Interleukin 18)IBA 09/2008
1	Vasoconstrictor AgentsIBA 10/2006
1	Exubera FDA Link 10/2006
1	Hormones (Hormone)IBA 09/2006
1	Pioglitazone (Actos)FDA Link 01/2006
1	EnzymesIBA 01/2006
1	Rosuvastatin Calcium (Crestor)FDA Link 09/2005
1	CholesterolIBA 09/2005
1	Lipoproteins (Lipoprotein)IBA 09/2005
1	ThiazolidinedionesIBA 07/2005
1	Plasminogen Activator Inhibitor 1IBA 07/2005
1	LeptinIBA 07/2005
1	Troglitazone (Rezulin)FDA Link 07/2005
1	Plasminogen Activators (Plasminogen Activator)IBA 07/2005
1	Tissue Plasminogen Activator (Alteplase)FDA Link 07/2005
1	Hepatocyte Nuclear FactorsIBA 05/2005
1	Apolipoprotein A-II (Apolipoprotein A2)IBA 05/2005
1	Insulin Lispro (Humalog)FDA Link 01/2003
1	SalicylatesIBA 12/2001
1	Hepatocyte Nuclear Factor 1-betaIBA 09/2001
1	Glucosamine (Dona)IBA 05/2001
1	HexosaminesIBA 05/2001
1	GlycogenIBA 02/2000

Therapy/Procedure

9	Therapeutics 09/2017 - 01/2003
2	Jet Injections 11/2015 - 01/2013
1	Polypharmacy 01/2021
1	Subcutaneous Injections 10/2006
1	Injections 04/2006